Form D · Other Health Care

SymKardia, Inc.

Westlake, OH · CIK 0002141283

Offering snapshot reported Oct 28, 2026 · SEC filing

Reported sold
$4M
Offering amount: $4M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 10, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 28, 2026Initial$4,000,000No comparison8SEC filing
Oct 28, 2026Amendment$4,300,000$3,800,000vs Jun 18, 20263SEC filing
Jun 18, 2026Initial$500,000No comparison1SEC filing

Offering details

Securities
Debt, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-602791
Convertible notes and equity issuable upon any conversion thereof

Source: Form D, filed Oct 28, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James Blouzard Director
Anthony Caparso Director, Executive
Alain Garcinuno Collet Director
Steven Girouard Executive
Bruce Ken Knight Executive
Imad Libbus Executive
Robert Picarel Director
Jonathan Piccini Executive
Claudio Rumazza Director
Dwight Skinner Executive
Arun Sridhar Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
159 Crocker Park Boulevard Suite 400
Westlake, OH, 44145